CrossrefInfokarte
First in humans: A new molecularly defined vaccine shows excellent safety and strong induction of long-lived Mycobacterium tuberculosis -specific Th1-cell like responses
Human Vaccines · 2010-12 · 6 (12) · 1007-1015
DOI: 10.4161/hv.6.12.13143 ↗Abstract
Kein Abstract verfügbar.
EUVIMED